DNA ploidy in nonmelanoma skin cancer

June K. Robinson*, Alfred W. Rademaker, Charles Goolsby, Thomas N. Traczyk, Carol Zoladz

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

24 Scopus citations


BACKGROUND. Patients with head and neck squamous cell carcinoma die of locoregional recurrence and those with basal cell carcinoma suffer cosmetic and functional changes from its treatment. Prognostic factors are based upon tumor characteristics and host factors. Flow cytometry can assist with prognostic characterization of nonmelanoma skin cancer. METHODS. Specimens from 40 sequential patients with head and neck nonmelanoma skin cancers were prospectively obtained at the time of surgery. The patients were followed for four years for local recurrence and metastasis to regional lymph nodes. Samples were prepared from frozen specimens using a modification of the Vindelov procedure. RESULTS. DNA aneuploidy or tetraploidy and histology of well differentiated squamous cell carcinoma were significantly associated with metastasis to regional lymph nodes. Direct extension of tumor below the adipose tissue was associated with an S-phase greater than 4.' and a proliferative fraction greater than 5.5. No tumors recurred at the site of surgical resection. CONCLUSIONS. The measurement of DNA ploidy of well differentiated squamous cell carcinoma, and proliferative capacity or S- phase of both basal cell and squamous cell carcinomas assists to predicting the biologic proclivity for locoregional invasion or metastasis of nonmelanoma skin cancer. Identification of aggressive tumors at the time of surgery may offer the opportunity for prevention of lethal metastasis by using adjunctive therapy.

Original languageEnglish (US)
Pages (from-to)284-291
Number of pages8
Issue number2
StatePublished - Jan 15 1996


  • DNA ploidy
  • metastasis
  • nonmelanoma skin cancer
  • prognosis

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'DNA ploidy in nonmelanoma skin cancer'. Together they form a unique fingerprint.

Cite this